Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment project

Binghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.

Novartis reportedly decides to pass on Cytokinetics

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hiya! Did you catch

January 12, 2024

Anti-rheumatic drugs could have a preventive effect on autoimmune thyroid disease

Anti-rheumatic drugs used for rheumatoid arthritis might prevent the development of autoimmune thyroid disease, according to a new observational study by researchers from Karolinska Institutet

November 22, 2023

Study exposes the dangerous ‘hidden’ mental burden of cancer on patients’ spouses

The distress from receiving a cancer diagnosis is something that clinicians widely anticipate in patients, but suffering often doesn’t just afflict the patient. It can

August 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.